Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Found 3371 publications
Metabolic Syndrome - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Metabolic Syndrome - Pipeline Review, H1 2014’, provides an overview of the Metabolic Syndrome’s therapeutic pipeline. This report provides ... RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Mar, 2014 95 pages
Actinic (Solar) Keratosis - Pipeline Review, H1 2014 US$ 2,000.00

... Review, H1 2014’, provides an overview of the Actinic (Solar) Keratosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Mar, 2014 89 pages
Market Research Report on Global and Chinese Escherichia coli Industry, 2009-2019 US$ 2,400.00

... manufacturers of Escherichia coli listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Escherichia coli by calculation of main economic parameters of each company; The breakdown ...

Apr, 2014 150 pages
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth US$ 3,500.00

... GBI Research has released its latest research report, entitled,'HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent ... market expansion strategies by identifying the potential region and HIV/AIDS therapeutics market segments poised for strong growth. Create a more ...

Apr, 2014 170 pages
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant US$ 3,500.00

... business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows ... , and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for pancreatic ...

Apr, 2014 122 pages
Global Glaucoma Therapeutics Market 2014-2018 US$ 2,500.00

... inhibitors, and fixed dose combinations. TechNavio's analysts forecast the Global Glaucoma Therapeutics market will grow at a CAGR of 2.53 percent over the period ... report also includes a discussion of the key vendors operating in this market. Key Regions Americas EMEA APAC Key Vendors Allergan Inc ...

Apr, 2014 74 pages
Oxford BioTherapeutics Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of Oxford BioTherapeutics Ltd’s human therapeutic ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Oxford BioTherapeutics Ltd’s pipeline products Reasons ...

Mar, 2014 20 pages
Istituto Italiano di Tecnologia - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Istituto Italiano di Tecnologia’s pipeline products Reasons ...

Mar, 2014 24 pages
Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2014 US$ 2,000.00

... , H1 2014’, provides an overview of the Herpes Labialis (Oral Herpes)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Mar, 2014 50 pages
Trino Therapeutics Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... indicated disease. Scope The report provides brief overview of Trino Therapeutics Ltd including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Trino Therapeutics Ltd’s pipeline products Reasons ...

Feb, 2014 18 pages
Skin Inflammation - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Skin Inflammation - Pipeline Review, H1 2014’, provides an overview of the Skin Inflammation’s therapeutic pipeline. This report provides ... key players involved in the therapeutics development for Skin Inflammation and enlists all their major and minor projects The report ...

Feb, 2014 42 pages
Respiratory Depression - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Respiratory Depression - Pipeline Review, H1 2014’, provides an overview of the Respiratory Depression’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Respiratory Depression, complete with comparative analysis at ...

Feb, 2014 44 pages
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014 US$ 2,000.00

... , H1 2014’, provides an overview of the Opioid-Induced Constipation (OIC)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Feb, 2014 88 pages
Neurofibromatoses Type II - Pipeline Review, H1 2014 US$ 2,000.00

... Neurofibromatoses Type II - Pipeline Review, H1 2014’, provides an overview of the Neurofibromatoses Type II’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Neurofibromatoses Type II, complete with comparative analysis at various stages, therapeutics ...

Feb, 2014 39 pages
Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014 US$ 2,000.00

... ’s, ‘Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Neuro Endocrine (Carcinoid) Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Neuro Endocrine (Carcinoid) Carcinoma, complete with comparative ...

Feb, 2014 87 pages
Hypertrophic Scars - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Hypertrophic Scars - Pipeline Review, H1 2014’, provides an overview of the Hypertrophic Scars’s therapeutic pipeline. This report provides ... RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Feb, 2014 45 pages
Familial Adenomatous Polyposis Coli - Pipeline Review, H1 2014 US$ 2,000.00

... , H1 2014’, provides an overview of the Familial Adenomatous Polyposis Coli’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... for Familial Adenomatous Polyposis Coli and enlists all their major and minor projects The report summarizes all the dormant ...

Feb, 2014 42 pages
Botulism - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Botulism - Pipeline Review, H1 2014’, provides an overview of the Botulism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Botulism, complete with comparative analysis at various stages, therapeutics assessment by ...

Feb, 2014 43 pages
Bone Therapeutics SA - Product Pipeline Review - 2014 US$ 1,500.00

... overview of Bone Therapeutics SA including business description, key information and facts, and its locations and subsidiaries The report reviews current ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Bone Therapeutics SA’s pipeline products ...

Feb, 2014 22 pages
Arteriosclerosis - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Arteriosclerosis - Pipeline Review, H1 2014’, provides an overview of the Arteriosclerosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Arteriosclerosis, complete with comparative analysis at various stages, ...

Feb, 2014 69 pages
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H1 2014 US$ 2,000.00

... Review, H1 2014’, provides an overview of the Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C’s therapeutic pipeline. This report provides comprehensive information ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Feb, 2014 39 pages
Market Research Report on Global and Chinese UV Therapy System Industry, 2009-2019 US$ 2,400.00

... System listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 ... economic parameters of each company; The breakdown data of UV Therapy System market are presented by company, by country, and by application; The report also ...

Feb, 2014 150 pages
Market Research Report on Global and Chinese Sleep therapy system Industry, 2009-2019 US$ 2,400.00

... therapy system listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 ... parameters of each company; The breakdown data of Sleep therapy system market are presented by company, by country, and by application; The report also ...

Feb, 2014 150 pages
Market Research Report on Global and Chinese Radiotherapy Simulator Industry, 2009-2019 US$ 2,400.00

... China’s total market of Radiotherapy Simulator by calculation of main economic parameters of each company; The breakdown data of Radiotherapy Simulator market are presented by company, by country, and by application; The report also estimates 2014-2019 market development of Radiotherapy Simulator Industry. ...

Feb, 2014 150 pages
Market Research Report on Global and Chinese Phototherapy System Industry, 2009-2019 US$ 2,400.00

... System listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 ... economic parameters of each company; The breakdown data of Phototherapy System market are presented by company, by country, and by application; The report also ...

Feb, 2014 150 pages
Market Research Report on Global and Chinese ECT Industry, 2009-2019 US$ 2,400.00

... of ECT listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global ... of main economic parameters of each company; The breakdown data of ECT market are presented by company, by country, and by application; The report also ...

Mar, 2014 150 pages
Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global... US$ 4,795.00

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such ... , sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the ...

Mar, 2014 90 pages
Global Diabetic Nephropathy Market 2014-2018 US$ 2,500.00

... market. TechNavio's report, the Global Diabetic Nephropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from ... . The report also includes a discussion of the Key Vendors operating in this market. Key Regions Americas EMEA APAC Key Vendors Merck & Co. Inc. ...

Mar, 2014 64 pages
Cell Therapy Deals and Alliances of 2013 US$ 1,495.00

The Cell Therapy Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements ... and figures that illustrate the trends and activities in bigpharma partnering and dealmaking during 2012. In conclusion, this report provides everything a ...

Mar, 2014 200 pages
Cancer Gene Therapy Market Analysis US$ 1,800.00

... clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus ... Involved with Application of Gene Therapy in Cancer Patients Regulatory Scenario for Gene Therapy Market Cancer Gene Therapy Drug Clinical Trial ...

Mar, 2014 300 pages
NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool US$ 3,500.00

... business intelligence provider, has released its latest research, "NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous ... and gain insights into how they are likely to compete in the market and who their main competitors will be Follow the trends ...

Mar, 2014 109 pages
Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns US$ 3,500.00

... Summary GBI Research has released its pharma research, "Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms ... restricting influence of generic competition as a result of recent patent expiries in all major markets of two key branded drugs, Keppra and Lamictal. Scope ...

Mar, 2014 74 pages
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability US$ 3,500.00

... business intelligence provider, has released its latest research, "Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next ... of drugs with novel mechanisms of action which could expand the therapeutic scope. Conversely, the growth of the market in APAC region could ...

Mar, 2014 66 pages
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment US$ 195.00

... examines the Causes of ADHD including Genetics Environmental and Social causes. Attention Deficit Hyperactivity Disorder ADHD is one of the more common mental ... settings including home school and in relationships with peers. If untreated the disorder can have long-term adverse effects into adolescence and ...

Nov, 2012 95 pages
Global RNA Interference (RNAi) Therapy Market Outlook 2018 US$ 1,800.00

... therapy. Being a powerful tool for the study of functional genomics, this therapy provides enables the scientist to successfully silence any gene with ... technology and enjoy the benefits. Global RNAi Therapy Report Highlights: Introduction & Need Analysis of RNAi Therapy Benefits & Drug Delivery Mechanics ...

Mar, 2014 300 pages
2014 Market Research Report on Global Nitric Oxide Therapy Instrument Industry US$ 2,850.00

'2014 Market Research Report on Global Nitric Oxide Therapy Instrument Industry' was a professional and depth research report on Global Nitric Oxide Therapy ... , cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, ...

Mar, 2014 176 pages
United States and Japan – Proton Therapy Market, Patients & Forecast US$ 1,475.00

... for more proton therapy centers are very high. This report is divided into 14 Chapters A. United States Proton Therapy Market – Actual ... IBA Proton Therapy 2. Optivus Proton Therapy 3. Hitachi Proton Therapy 4. Mevion Proton Therapy 5. Varian Proton Therapy Chapter No. 11 speaks of Proton Therapy centers ...

Mar, 2014 75 pages
Global Cell Therapy Market & Pipleine Insight US$ 2,400.00

... the future of medicine. As the life of a human being begins as a cell, these cells undergo a highly complex set of events and finally those ... continuous advances and developments in this field of medicine, the global cell therapy market is expected to grow at a high rate of 20-22% to reach approximately USD 8 ...

Mar, 2014 500 pages
Global Peptide Therapeutics Market & Pipeline Insight US$ 2,400.00

... in the pre-clinical studies. There are many applications of the peptide drugs. The most popular and dominant segments include cancer ... demand for peptide drugs, this market is expected to grow at a CAGR of 9-10% to reach approximately USD 27.3 billion by 2018. “Global Peptide Therapeutics Market & Pipeline ...

Feb, 2014 1350 pages
PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update US$ 9,995.00

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update Summary Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. ...

Apr, 2013 338 pages
Isarna Therapeutics GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries. Review of current pipeline of Isarna Therapeutics GmbH human therapeutic division. Overview ... milestones. Recent updates of the Isarna Therapeutics GmbH’s pipeline in the last quarter. Key discontinued and dormant projects. Latest news and ...

Jan, 2014 42 pages
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth US$ 3,500.00

... Growth Summary GBI Research has released its pharma report “Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and ... patterns, annual therapy costs and market growth in the eight major markets and understand reasons for variance in projected patterns of growth ...

Feb, 2014 101 pages
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth US$ 3,500.00

... intelligence provider, has released its latest research report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive ... the effects of key patent losses during the forecast period. Cystic Fibrosis Transmembrane conductance Regulators (CFTR) modulators are the first ...

Feb, 2014 76 pages
OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecasts to 2017 US$ 5,995.00

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecasts to 2017 Summary Endometriosis is a gynecological disorder affecting women of childbearing age. This inflammatory condition is characterized by the growth of endometrial tissues outside of the uterus, and can cause chronic painful ...

Dec, 2013 138 pages
Advanced in the Rheumatoid Arthritis Market US$ 1,545.00

Rheumatoid arthritis (RA) is a chronic disorder for which there is currently no cure. It affects around 23.5 million adults in the world (WHO, 2013) and approximately 294,000 children under the age of 18 are affected by pediatric arthritis and other rheumatologic conditions (PhRMA, 2013).

Jan, 2014 85 pages
Global Proton Therapy Market: Trends & Opportunities (2013-2018) US$ 800.00

The report titled “Global Proton Therapy Market: Trends and Opportunities (2013-2018)” analyzes the potential opportunities and significant trends in the global ... and this technology holds immense potential as evident in the growing number of proton centers across the world. One of the chief arguments against ...

Feb, 2014 68 pages
Tachycardia (Tachyarrhythmias) - Pipeline Review, H2 2013 US$ 2,000.00

... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Tachycardia (Tachyarrhythmias). Tachycardia (Tachyarrhythmias) - Pipeline Review, Half Year is built using data and information sourced from Global Markets ...

Dec, 2013 33 pages
Sage Therapeutics - Product Pipeline Review - 2013 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries. Review of current pipeline of Sage Therapeutics human therapeutic division. Overview ... of the Sage Therapeutics’s pipeline in the last quarter. Key discontinued and dormant projects. Latest news and deals relating to the products ...

Dec, 2013 35 pages
Ocular Therapeutix, Inc. - Product Pipeline Review - 2013 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries. Review of current pipeline of Ocular Therapeutix, Inc. human therapeutic division. Overview ... milestones. Recent updates of the Ocular Therapeutix, Inc.’s pipeline in the last quarter. Key discontinued and dormant projects. Latest news and ...

Dec, 2013 23 pages
Northern Therapeutics, Inc. - Product Pipeline Review - 2013 US$ 1,500.00

... molecules in various stages of drug development, including the combination treatment modalities, across the globe. Product profiles for late stage and ... milestones. Recent updates of the Northern Therapeutics, Inc.’s pipeline in the last quarter. Key discontinued and dormant projects. Latest news and ...

Dec, 2013 20 pages
1 2 3 4 5 >
Skip to top